a transcription factor that contains both basic helix-loop-helix and leucine zipper structural features. Plays a critical role in the differentiation of various cell types including neural crest- derived melanocytes, mast cells, osteoclasts and optic cup-derived retinal pigment epithelium. Two isoforms are known: the M-isoform is expressed exclusively in melanocytes, while the A-isoform has a much broader range of expression. Mutations in MITF can lead to Waardenburg syndrome. Ten alternatively spliced isoforms have been described. Note: This description may include information from UniProtKB.
Protein type: Oncoprotein; Transcription factor; DNA-binding
Cellular Component: nucleoplasm; nucleus; protein complex
Molecular Function: chromatin binding; protein binding; protein dimerization activity; RNA polymerase II transcription factor activity, enhancer binding
Biological Process: bone remodeling; camera-type eye development; cell fate commitment; cellular protein metabolic process; melanocyte differentiation; negative regulation of transcription from RNA polymerase II promoter; osteoclast differentiation; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; post-translational protein modification; protein complex assembly; protein sumoylation; regulation of cell proliferation; regulation of osteoclast differentiation; regulation of transcription, DNA-dependent; transcription from RNA polymerase II promoter
LTP: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.